India Advanced Diagnostic Imaging Equipment (MRI, CT, Ultrasound) Manufacturing Market Strategic Research Report

India's advanced diagnostic imaging equipment manufacturing market — encompassing magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, and ultrasound devices — represents one of the most strategically consequential segments within the country's broader medical technology ecosystem. Valued at approximately USD 1.42 billion in 2024, the Indian market reflects both the country's acute demand-supply imbalance in diagnostic infrastructure and an accelerating policy-driven push toward domestic manufacturing. India currently ranks among the top five global markets by volume of diagnostic imaging procedures performed annually, yet domestic manufacturing accounts for less than 20% of installed equipment value — a structural gap that is now attracting significant capital from both multinational corporations establishing local production lines and Indian industrial conglomerates entering the medtech space.

Three intersecting forces are reshaping the market's growth trajectory through 2032. First, the Government of India's Production Linked Incentive (PLI) scheme for medical devices — offering incentives of up to 5% on incremental sales for qualifying manufacturers — has materially altered the investment calculus for domestic production, drawing committed capital from firms that previously operated purely as importers. Second, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) scheme, covering over 500 million beneficiaries, is directly expanding institutional demand for imaging equipment in tier-2 and tier-3 cities, where private diagnostic chains and district hospitals are scaling capacity. Third, India's chronic shortage of radiologists relative to imaging equipment installed base — at roughly 1 radiologist per 100,000 population against a recommended ratio nearly three times higher — is driving adoption of AI-assisted imaging platforms that increase throughput per machine, raising the average selling price and technical sophistication of new equipment procured. The primary restraint remains the deep import dependency on core components: superconducting magnets for MRI systems, X-ray tubes for CT scanners, and piezoelectric transducer arrays for ultrasound probes are sourced predominantly from Germany, Japan, and China, exposing domestic manufacturers to currency and supply-chain risks that compress margins and complicate capacity planning.

This report provides corporate strategy teams, investment analysts, M&A advisors, and procurement managers with a comprehensive, data-anchored examination of India's advanced diagnostic imaging equipment manufacturing market from 2019 through 2032. Coverage spans market sizing and volumetric forecasts, segmentation by equipment type and end-use application, state-level demand analysis, competitive intelligence on ten major players operating in the Indian manufacturing landscape, and a structured assessment of the regulatory, technological, and macroeconomic forces shaping the market's evolution. Decision-makers evaluating capacity investments, joint-venture structures, or procurement strategy for public or private healthcare systems will find this report an essential reference.